Trailing-twelve-month (TTM) revenue is $18.11 Billion with a year-over-year growth of +10.05%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $4,495,245,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $4,486,048,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-25 |
| Q1 FY2026Period ended 2026-03-31 | $4,495,182,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $4,638,012,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $18,114,487,000 |
Current P/S: $10,827,531,919 market capitalization ÷ $18,114,487,000 TTM revenue = 0.60x.
Market capitalization source: FMP quote. Quote observed 2026-09-25T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $4.64B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-25T21:56:23.881Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2023-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Acute Care Hospital Services | $30.6B | $7.1B | $7.6B | $8.1B | $8.9B | $9.9B |
| All Other Segments | N/A | $30M | $23M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD |
|---|---|---|---|
| Behavioral Health Services | $688M | $685M | $761M |
$18.11B
$18.11 Billion
+10.05%
vs. $16.46B a year ago (TTM)
+8.21%
5 Year compound annual growth rate
1 Year
+10.05%
3 Year
+9.49%
5 Year
+8.21%
10 Year
+6.75%
15 Year
+6.86%
20 Year
+7.82%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $17.36B | +$1.54B | +9.71% |
| 2024 | $15.83B | +$1.55B | +10.82% |
| 2023 | $14.28B | +$882.61M | +6.59% |
| 2022 | $13.40B | +$757.25M | +5.99% |
| 2021 | $12.64B | +$1.08B | +9.37% |
| 2020 |
TTM Growth
+10.05%
3-Year CAGR
+9.49%
5-Year CAGR
+8.21%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-25T21:56:23.881Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| Behavioral Health Services | $9.7B | $5.5B | $5.7B | $6.2B | $6.9B | $7.4B |
|---|
| $11.56B |
| +$180.64M |
| +1.59% |
| 2019 | $11.38B | +$605.98M | +5.63% |
| 2018 | $10.77B | +$362.41M | +3.48% |
| 2017 | $10.41B | +$643.65M | +6.59% |
| 2016 | $9.77B | +$722.76M | +7.99% |
